Name (Synonyms) | Correlation | |
---|---|---|
drug2862 | Telmisartan Wiki | 0.58 |
drug313 | Azithromycin Wiki | 0.17 |
drug1284 | Hydroxychloroquine Wiki | 0.10 |
Name (Synonyms) | Correlation | |
---|---|---|
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.09 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This is a pilot phase, open label, non-randomized study for the treatment of ARDS in patients infected with COVID-19. Subjects will be enrolled and treated with one dose of mesenchymal stem cells and follow-up will occur 90 days post-treatment.
Description: Number of patients with changes in percentage of resting Oxygen saturation (%O2)
Measure: Oxygen saturation Time: Baseline, and at days 2, 4 and 14 post-treatmentDescription: Changes in mmHg of Arterial partial pressure of oxygen / Fraction of inspiration O2 (PaO2/FiO2) in all participants
Measure: Oxygen pressure in inspiration Time: Baseline, and at days 2, 4 and 14 post-treatmentDescription: Changes in percentage of participants with reduction in bilateral ground-glass opacities
Measure: ground-glass opacity Time: Baseline, and at day 14 post-treatmentDescription: Changes in percentage of participants with reduction of pneumonia bilateral infiltration
Measure: Pneumonia infiltration Time: Baseline, and at day 14 post-treatmentDescription: Number of participants with a reduction in Lactate dehydrogenase (mg/dL)
Measure: Lactate dehydrogenase Time: Baseline, and at days 4 and 14 post-treatmentDescription: Number of participants with a reduction in C-reactive protein (mg/dL)
Measure: C-reactive protein Time: Baseline, and at days 4 and 14 post-treatmentDescription: Number of participants with a reduction in D-dimer (mg/dL)
Measure: D-dimer Time: Baseline, and at days 4 and 14 post-treatmentDescription: Number of participants with a reduction in Ferritine (mg/dL)
Measure: Ferritine Time: Baseline, and at days 4 and 14 post-treatment